Core Viewpoint - Targeted policies and research reforms are essential to bridge the gaps in women's health research, which is currently insufficient despite higher healthcare service usage by women [3][4][5]. Group 1: Current State of Women's Health Research - Women's healthcare service usage is higher than men's, yet systematic research on women's health remains inadequate, leading to significant health risks [3][4]. - The medical information and treatments available are primarily based on male biology, neglecting the unique health needs of women [4]. - Women experience a longer lifespan but spend 25% more of their lives in poor health or with disabilities compared to men [5]. Group 2: Impact of Gender-Specific Research Gaps - Only 7% of medical research focuses on diseases that exclusively affect women, and there is a significant lack of gender-specific data in clinical trials [6][9]. - Women with chronic diseases face dilemmas regarding medication use during pregnancy, often risking unapproved drugs or halting treatment altogether [7]. - The absence of gender-specific data in clinical trials can lead to ineffective treatments and increased health risks for women [9]. Group 3: Policy Recommendations for Improvement - The white paper "Prescription for Change: Policy Recommendations for Women's Health Research" outlines strategic pathways to reduce the research gap, including regulatory reforms and financial incentives to encourage investment in women's health [10][11]. - Increasing female representation in clinical trials is crucial for improving health outcomes, particularly in key areas like cardiology and oncology [12]. - Standardizing data collection and promoting gender-specific risk-benefit assessments are necessary for better understanding unique gender effects [13]. Group 4: Designing Inclusive Clinical Trials - Education for researchers and trial staff on gender differences is vital for advancing women's health research [14]. - Clinical guidelines and drug labels should reflect gender-specific safety and efficacy data to ensure better health outcomes for women [15]. - Structural changes in clinical research are needed to ensure that innovations meet the diverse needs of women [17].